MicroBioGen
Elizabeth Wightman is a Molecular Biologist who has experience in developing superior Saccharomyces cerevisiae strains for industrial applications. Elizabeth has also worked as a Laboratory Tutor, Visiting Researcher, Data Technician, and Results Technician in various companies. Elizabeth holds a PhD in Synthetic Biology from Macquarie University, along with a Master of Research in Synthetic and Molecular Biology and a Bachelor of Science with a Double Major in Biochemistry and Neuroscience.
This person is not in any teams
This person is not in any offices
MicroBioGen
MicroBioGen is the world leader in the development of superior yeast biocatalysts for a wide range of industrial applications. The yeast biocatalysts we specialise in underpin products worth more than US$1 trillion per year. Our unique platform technology can also be applied to human food, animal feed, enzymes, protein vectors, probiotics, biochemicals and even space exploration. Together with our current and future valued partners, customers and shareholders, we are excited to be building a more sustainable future through our unique, proprietary, long term and high-tech development programs. Our highly advanced Saccharomyces cerevisiae yeast products – used for the Novozymes Innova series – are quickly becoming the new industry standards for the production of a range of 1st generation biofuels. We are also in the final stages of developing a yeast product in collaboration with a major global corporate for 2nd generation biofuels, with ARENA (The Australian Renewable Energy Agency) supporting us in a $8M optimisation programme.